SC
LLY icon

Stempoint Capital’s Eli Lilly LLY Stock Holding History

Stempoint Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,759
Closed -$5.11M – 103
2025
Q4 		$5.11M Buy
+4,759
New +$4.55M 0.88% 39
2024
Q2 		– Sell
-15,067
Closed -$11.7M – 61
2024
Q1 		$11.7M Hold
15,067
– – 3.1% 11
2023
Q4 		$8.78M Buy
+15,067
New +$8.79M 2.34% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stempoint Capital's LLY Position: Q1 2026 in Review

Stempoint Capital sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 4,759 shares — an estimated $5.11M sold.

Stempoint Capital first reported a position in LLY in Q4 2023 and held it in 3 quarters. The position peaked at $11.7M in Q1 2024. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stempoint Capital reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Stempoint Capital sold 4,759 Eli Lilly shares in Q1 2026, an estimated $5.11M.
  • Stempoint Capital first reported a position in Eli Lilly in Q4 2023 and held it in 3 quarters.
  • Stempoint Capital's Eli Lilly position peaked at $11.7M in Q1 2024.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.